Intercept to Announce Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

Rhea-AI Summary

Intercept Pharmaceuticals (Nasdaq: ICPT) will announce its fourth quarter and full year 2020 financial results on February 25, 2021, before market opening. The announcement will be followed by a conference call at 8:30 a.m. ET, where management will discuss the results. The conference call can be accessed via the investor website or through dedicated phone lines for domestic and international callers. Intercept focuses on therapeutics for progressive non-viral liver diseases such as primary biliary cholangitis and nonalcoholic steatohepatitis.

Positive

• Upcoming financial results announcement potentially signaling increased transparency for investors.

Negative

• None.

NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its fourth quarter and full year 2020 financial results prior to market open on Thursday, February 25, 2021. The announcement will be followed by a conference call and audio webcast hosted by Intercept management at 8:30 a.m. ET to discuss the results.

The conference call will be available on the investor page of our website at http://ir.interceptpharma.com or by calling (855) 232-3919 (toll-free domestic) or (315) 625-6894 (international) passcode 7565656. Archived webcasts will be available on Intercept’s website for approximately two weeks.

About Intercept

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries: investors@interceptpharma.com

Media inquiries: media@interceptpharma.com

Source: Intercept Pharmaceuticals, Inc.

FAQ

When will Intercept Pharmaceuticals release its financial results?

Intercept Pharmaceuticals will release its fourth quarter and full year 2020 financial results on February 25, 2021.

What time is the Intercept Pharmaceuticals conference call?

The conference call will take place at 8:30 a.m. ET on February 25, 2021.

How can I access the Intercept Pharmaceuticals conference call?

The conference call can be accessed on Intercept's investor website or by calling provided domestic and international phone numbers.

What is the focus of Intercept Pharmaceuticals?

Intercept Pharmaceuticals focuses on developing therapeutics for progressive non-viral liver diseases, including primary biliary cholangitis and nonalcoholic steatohepatitis.